Related Experiment Video
Updated: Sep 21, 2026
Tissue-simulating Phantoms for Assessing Potential Near-infrared Fluorescence Imaging Applications in Breast Cancer Surgery
Published on: September 19, 2014
Near-Infrared-IIb Fluorescent Nanozymes with Surface Charge Flipping Ability for Imaging-Guided Therapy of
Fushou Liu1, Tao Tang1, Jian Guo2
1College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China.
Inflammatory bowel disease (IBD) is a common chronic gastrointestinal inflammatory disease with an increasing global incidence. However, a significant challenge in IBD management lies in the coordination between high stability and targeting properties of diagnostic and therapeutic agents. Here, we engineer near-infrared-IIb (NIR-IIb) fluorescent nanozymes with pH-responsive surface charge flipping ability for imaging-guided therapy of IBD. The nanozymes exhibit protonation-induced positive charge (+2.6 mV) in gastric acid for enhanced stability, switching to negative charge (-7.2 mV) in intestinal fluid for targeted accumulation. Therefore, these NIR-IIb fluorescent nanozymes could markedly bypass gastric acid barriers and target damaged colon tissue, revealing a significant NIR-IIb signal in early-stage IBD models versus the control. Meanwhile, Mn doping confers a reactive oxygen species scavenging ability, alleviating inflammation in colitis mice. This dual-functional platform overcomes gastrointestinal barriers, enabling precise lesion targeting and therapy monitoring and offering a promising strategy for personalized IBD management.
Inflammatory bowel disease (IBD) is a common chronic gastrointestinal inflammatory disease with an increasing global incidence. However, a significant challenge in IBD management lies in the coordination between high stability and targeting properties of diagnostic and therapeutic agents. Here, we engineer near-infrared-IIb (NIR-IIb) fluorescent nanozymes with pH-responsive surface charge flipping ability for imaging-guided therapy of IBD. The nanozymes exhibit protonation-induced positive charge (+2.6 mV) in gastric acid for enhanced stability, switching to negative charge (-7.2 mV) in intestinal fluid for targeted accumulation. Therefore, these NIR-IIb fluorescent nanozymes could markedly bypass gastric acid barriers and target damaged colon tissue, revealing a significant NIR-IIb signal in early-stage IBD models versus the control. Meanwhile, Mn doping confers a reactive oxygen species scavenging ability, alleviating inflammation in colitis mice. This dual-functional platform overcomes gastrointestinal barriers, enabling precise lesion targeting and therapy monitoring and offering a promising strategy for personalized IBD management.
More Related Videos
10:55Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
Published on: January 5, 2015
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
